With all the disruption caused by COVID-19, can any silver linings be found? Through research and interviews with dozens of leaders, we have identified policies and practices that should remain to accelerate biomedical innovation well into the future. milkeninstitute.org/reports/biomed…

#ClinicalTrials2030 What would a more person-centered, inclusive #clinicaltrials enterprise look like in 2030? Join NASEM Health's #DrugForum and partners on Feb. 9 for a public workshop session to learn more: bit.ly/3gHAgW7

Pleased to join @FDAnews webinar “FDA under the Biden Administration: What’s to come and what it will mean” with Lowell Schiller, Aetion’s Chief Legal and Regulatory Officer, Wayne Pines (APCO Worldwide) and Marc Scheineson (Alston & Bird) lnkd.in/d4eVTey

I am proud @FasterCures is working hand-in-hand with the leaders from across multiple sectors supporting the more than 300 million people living with a rare disease. We stand with everyone working to make a difference on #RareDiseaseDay. Join today's Rare Disease Day at NIH!

Pleased to moderate a fantastic discussion today with leaders across biomedical innovation on the lessons learned from COVID 19 to move into the future.

Listen to the recording here! milkeninstitute.org/videos/lessons…

Thrilled to be releasing this report from FasterCures addressing the practical steps we must take to create a more effective early warning system to guard against future pandemics. The time to act on these recommendations is now.

We can stop the next #Covid19 from becoming a pandemic. That’s why FasterCures is working with @RockefellerFdnto improve pandemic preparedness &prevention:rockfound.link/News_PPI_TW#Me…

We created FasterCures our Research Partnership Maturity Model (RPMM) as a tool to enable growth for patient organization’s research programs. Learn more here, milkeninstitute.org/article/RPMM-c…

Reflecting on NIHDirector tenure leading @NIH, he has been a steadfast champion of our mission to lower the barriers to progress for patients. We are looking forward to seeing what the next chapter holds, but millions of patients have him to thank for the progress we see today.

Early cancer detection is crucial to decreasing mortality. @FasterCures' latest report discusses how new multi-cancer early detection (MCED) tests could change the cancer research and treatment field. milkeninstitute.org/report/multi-c…

I am pleased to see the Biden Administration’s nomination today of @califf001 to be the next Commissioner of the Food and Drug Administration. More than ever, it is critical that we have a permanent FDA Commissioner with a deep commitment to innovation and progress for patients.

TRAIN, FasterCures network of 110+ patient centered organizations interested in elevating their medical research impact, is looking for new members! TRAIN members have access to capacity building events, networking opportunities, and much more. Apply here milkeninstitute.org/centers/faster…

Pleased to share our latest @FasterCures paper on the landscape of trust frameworks in health data. We need to strengthen policies on transparent data sharing, notification of security breaches and protections against discriminatory use of data. milkeninstitute.org/report/trust-h…

A pandemic preparedness plan is not complete without addressing AMR, including fixing the broken antibiotic market. To provide new financing solutions FasterCures partnered with Milken Institute Financial Innovation Lab on a new report with key findings. bit.ly/3ivAYrl

A coordinated global early warning system is key to preventing future pandemics. @FasterCures new report details actionable recommendations for a coordinated effort to monitor for emerging pathogens. Read the full report here, bit.ly/3wPTwL1

There is no better time to prevent future pandemics than now. In our recent op-ed, Rick Bright and I call for global coordination to strengthen early warning capabilities across the world. See the piece here: fxn.ws/3jKu566

I am thrilled to share that @FasterCures selected the new LeadersLink cohort! This next cohort of emerging non-profit disease foundation leaders will focus on building their organization's patient data resources. Meet the 2022-23 cohort here bit.ly/3KW33on